Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.27B
Enterprise Value5.26B
P/E Ratio124.66
PEG Ratio-1.65
Price/Sales Ratio2.63
Price/Book Ratio0.98
Enterprise/Revenue2.47
Enterprise/EBITDA24.63

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.02
Operating Margin-0.02
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue1.73B
Revenue/Share1.38
Gross Profit563.3M
EBITDA312.47M
Net Income77M
Diluted EPS0.06

Balance Sheet

Total Cash807.14M
Total Cash/Share0.68
Total Debt382.58M
Total Debt/Equity0.09
Current Ratio2.36
Book Value Per Share3.72

Price History

52-Week Change-22.55
52-Week High5
52-Week Low3.24
Moving Average 50 Days3.82
Moving Average 200 Days3.95

Statistics

Average Volume18.49M
Shares Outstanding1.19B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.07
Trailing Annual Dividend Yield1.92
Payout Ratio4.42
Last Split Factor3:1
Last Split DateMay 10, 2017
AD